$INSE
Inspired Entertainment, Inc.

2016 Q4 Form 10-Q Financial Statement

#000114420416133410 Filed on November 10, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q4
Revenue $27.04M $0.00 $0.00
YoY Change
Cost Of Revenue $4.909M $6.344M $4.705M
YoY Change 4.34%
Gross Profit $22.13M -$6.344M -$4.705M
YoY Change -570.35%
Gross Profit Margin 81.84%
Selling, General & Admin $14.61M
YoY Change
% of Gross Profit 66.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.170M
YoY Change
% of Gross Profit 32.4%
Operating Expenses $21.77M $522.8K $724.5K
YoY Change 2904.73% -26.98% 425.09%
Operating Profit $360.0K -$522.8K -$5.430M
YoY Change -106.63% -26.98%
Interest Expense -$14.29M $40.00K $0.00
YoY Change
% of Operating Profit -3969.44%
Other Income/Expense, Net $1.220M
YoY Change
Pretax Income -$22.33M -$480.0K -$730.0K
YoY Change 2958.9% -33.33% 421.43%
Income Tax $50.00K
% Of Pretax Income
Net Earnings -$22.38M -$478.9K -$728.5K
YoY Change 2971.96% -33.55% 427.99%
Net Earnings / Revenue -82.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.792M -$151.9K -$248.3K
COMMON SHARES
Basic Shares Outstanding 6.585M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.90M $200.0K $300.0K
YoY Change 10200.0% -50.0% -72.73%
Cash & Equivalents $200.0K $256.2K
Short-Term Investments
Other Short-Term Assets $7.700M $0.00 $100.0K
YoY Change 7600.0% -100.0% -50.0%
Inventory $6.800M
Prepaid Expenses $62.59K
Receivables $26.00M
Other Receivables $100.0K
Total Short-Term Assets $71.50M $200.0K $318.8K
YoY Change 22325.88% -60.0% -75.24%
LONG-TERM ASSETS
Property, Plant & Equipment $44.30M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.100M $80.00M $80.00M
YoY Change -98.63% 0.0% 0.0%
Total Long-Term Assets $138.1M $80.10M $80.01M
YoY Change 72.6% 0.13% 0.0%
TOTAL ASSETS
Total Short-Term Assets $71.50M $200.0K $318.8K
Total Long-Term Assets $138.1M $80.10M $80.01M
Total Assets $209.6M $80.30M $80.33M
YoY Change 160.92% -0.25% -1.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.10M $3.800M $2.600M
YoY Change 326.92% 80.95% 2500.0%
Accrued Expenses $16.20M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $200.0K $0.00
YoY Change
Long-Term Debt Due $17.20M
YoY Change
Total Short-Term Liabilities $60.60M $4.478M $2.646M
YoY Change 2190.39% 112.9% 2983.94%
LONG-TERM LIABILITIES
Long-Term Debt $100.8M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $32.00M $2.800M $2.800M
YoY Change 1042.86% 0.0% 0.0%
Total Long-Term Liabilities $132.8M $2.800M $2.800M
YoY Change 4642.86% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.60M $4.478M $2.646M
Total Long-Term Liabilities $132.8M $2.800M $2.800M
Total Liabilities $193.4M $7.278M $5.446M
YoY Change 3451.34% 48.53% 88.71%
SHAREHOLDERS EQUITY
Retained Earnings -$5.569M -$3.668M
YoY Change 89.49% 2491.51%
Common Stock $320.00 $301.00
YoY Change 8.84% 13.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.10M $5.000M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $209.6M $80.26M $80.33M
YoY Change 160.92% -0.32% -1.19%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q4
OPERATING ACTIVITIES
Net Income -$22.38M -$478.9K -$728.5K
YoY Change 2971.96% -33.55% 427.99%
Depreciation, Depletion And Amortization $7.170M
YoY Change
Cash From Operating Activities -$8.070M -$250.0K -$150.0K
YoY Change 5280.0% 525.0% 7.14%
INVESTING ACTIVITIES
Capital Expenditures -$7.630M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $50.00K $0.00
YoY Change -100.0%
Cash From Investing Activities -$7.730M $50.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 44.99M 200.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -8.070M -250.0K -150.0K
Cash From Investing Activities -7.730M 50.00K 0.000
Cash From Financing Activities 44.99M 200.0K 0.000
Net Change In Cash 29.19M -0.00000000008731 -150.0K
YoY Change -19560.0% -100.0% -114.02%
FREE CASH FLOW
Cash From Operating Activities -$8.070M -$250.0K -$150.0K
Capital Expenditures -$7.630M
Free Cash Flow -$440.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 hdrau Minimum Value Of Net Tangible Assets Shares Redeemed
MinimumValueOfNetTangibleAssetsSharesRedeemed
5000001 USD
CY2015Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
80009479 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4477991 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2645838 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2800000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2800000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
7277991 USD
CY2016Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
80017988 USD
CY2015Q4 us-gaap Liabilities
Liabilities
5445838 USD
CY2016Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
67982254 USD
CY2015Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
69883968 USD
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
320 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
301 USD
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10569130 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8667435 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5569449 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3667735 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
5000001 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80260246 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80329807 USD
CY2016Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
500000 USD
CY2015Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
522752 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
715863 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-522752 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-715863 USD
CY2016Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
48213 USD
CY2015Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1372 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-478933 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-720771 USD
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3156561 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2868313 shares
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2016Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-4394 USD
CY2015Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6280 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2805920 USD
us-gaap Operating Expenses
OperatingExpenses
2805920 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
6473 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6280 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14520 USD
us-gaap Net Income Loss
NetIncomeLoss
-2797680 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2735736 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.02
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-38839 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1350 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2017658 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-717421 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
109 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-717530 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
405748 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
8020 USD
hdrau Payment Of Offering Costs And Operational Costs Pursuant To Related Party Advances
PaymentOfOfferingCostsAndOperationalCostsPursuantToRelatedPartyAdvances
44 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-69491 USD
CY2014Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
250000 USD
CY2016Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
500000 USD
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
104498 USD
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
0 USD
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
104498 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2014Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
80000000 USD
CY2014Q4 us-gaap Share Price
SharePrice
10.00
CY2014Q4 hdrau Cash Available For Fund Operations
CashAvailableForFundOperations
1326704 USD
CY2016Q3 us-gaap Share Price
SharePrice
10.00
CY2016Q3 hdrau Working Capital
WorkingCapital
4235883 USD
us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
18000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000 shares
CY2016Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
1300000 USD
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
29000000 shares
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3203303 shares
CY2016Q3 hdrau Common Stock Redemption Shares
CommonStockRedemptionShares
6796697 shares
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Hydra Industries Acquisition Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001615063
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Trading Symbol
TradingSymbol
HDRAU
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6584608 shares
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
29000000 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3203303 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3012432 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3012432 shares
CY2015Q4 hdrau Common Stock Redemption Shares
CommonStockRedemptionShares
6987568 shares
hdrau Common Stock Subject To Redemption Shares
CommonStockSubjectToRedemptionShares
6796697 shares
hdrau Common Stock Subject To Redemption Shares
CommonStockSubjectToRedemptionShares
7060059 shares
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
200000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2016Q3 hdrau Minimum Fair Market Value Of Target Business As Percentage Of Assets Held In Trust
MinimumFairMarketValueOfTargetBusinessAsPercentageOfAssetsHeldInTrust
0.8 pure
hdrau Liquidation Condition
LiquidationCondition
If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering (the Combination Period), the Company will (i) cease all operations except for the purposes of winding up its affairs; (ii) distribute the aggregate amount then on deposit in the Trust Account, including a portion of the interest earned thereon (net of any taxes payable, and less up to $50,000 of interest to pay dissolution expenses), pro rata to the Companys public stockholders by way of redemption of the Companys public shares (which redemption would completely extinguish such holders rights as stockholders, including the right to receive further liquidation distributions, if any); and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Companys net assets to its remaining stockholders, as part of the Companys plan of dissolution and liquidation.
CY2016Q1 us-gaap Line Of Credit Facility Capacity Available For Specific Purpose Other Than For Trade Purchases
LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
250000 USD
CY2016Q3 us-gaap Line Of Credit Facility Capacity Available For Specific Purpose Other Than For Trade Purchases
LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
100000 USD
CY2016Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
700000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Use of estimates</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Concentration of credit risk</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At September 30, 2016, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3 us-gaap Loss Contingency Range Of Possible Loss Portion Not Accrued
LossContingencyRangeOfPossibleLossPortionNotAccrued
973000 USD
CY2016Q3 hdrau Transaction Fees
TransactionFees
650000 USD
CY2016Q3 hdrau Promissory Notes Payable Related Party Current
PromissoryNotesPayableRelatedPartyCurrent
200000 USD
CY2015Q4 hdrau Promissory Notes Payable Related Party Current
PromissoryNotesPayableRelatedPartyCurrent
0 USD

Files In Submission

Name View Source Status
0001144204-16-133410-index-headers.html Edgar Link pending
0001144204-16-133410-index.html Edgar Link pending
0001144204-16-133410.txt Edgar Link pending
0001144204-16-133410-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdrau-20160930.xml Edgar Link completed
hdrau-20160930.xsd Edgar Link pending
hdrau-20160930_cal.xml Edgar Link unprocessable
hdrau-20160930_def.xml Edgar Link unprocessable
hdrau-20160930_lab.xml Edgar Link unprocessable
hdrau-20160930_pre.xml Edgar Link unprocessable
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_004.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v451695_10q.htm Edgar Link pending
v451695_ex10-2.htm Edgar Link pending
v451695_ex31-1.htm Edgar Link pending
v451695_ex31-2.htm Edgar Link pending
v451695_ex32-1.htm Edgar Link pending
v451695_ex32-2.htm Edgar Link pending